Venture Capital Concentration and the Valuation Paradox of AI

Illustration by John Doe
Illustration by John Doe

The US venture market is increasingly defined by massive capital concentration in AI and a widening valuation gap between recent vintages and legacy holdings.

The United States venture capital landscape has entered a period of extreme capital concentration, with megadeals of $100 million or more accounting for 87.5% of total dollars deployed during the first half of 2026. Data published by PitchBook in its Q2 US VC Valuations report on 10 August reveals that artificial intelligence serves as the primary engine behind this trend, creating a bifurcated market where valuation premiums are increasingly tied to sector-specific momentum rather than traditional performance metrics.

The disparity between AI-focused enterprises and the broader market is evident in valuation step-ups, where AI companies achieved a median 2.2x increase compared to 1.6x for non-AI firms. At the Series A level, pre-money valuations for AI startups are roughly double those of their non-AI counterparts, a gap that expands to 6.6x by Series D and beyond. Emily Zheng, a senior research analyst at PitchBook, identified a dramatic acceleration in value creation, noting that the median velocity of value creation for late-stage AI firms surged from $108.9 million in 2025 to $1,028 million this year.

This growth is heavily influenced by high-profile entities such as Anthropic, which saw its valuation climb 5.3x within an eight-month window. Consequently, the median AI pre-money valuation for late-stage rounds now stands at $3.95 billion. These figures underscore a market environment where capital is not distributed evenly, but rather funneled into a narrow cohort of firms perceived as having the highest potential for rapid, AI-driven scale.

Secondary market data provides a stark illustration of how investors are pricing companies based on the vintage of their last funding round rather than current business fundamentals. According to the secondary platform Forge, companies that secured primary funding in 2026 trade at no discount, whereas those from the 2021 vintage face a median discount of 59.1%. This phenomenon suggests that in the absence of fresh, verifiable price discovery, the market defaults to a temporal discount, penalizing older vintages regardless of their underlying revenue trajectory.

The acquisition of Brex by Capital One for $5.2 billion serves as a tangible example of this valuation compression, landing well within the 54% to 59% discount band observed for 2021 and 2022 vintages. While the fintech company once commanded a peak valuation of $12.3 billion, the final sale price reflects the harsh reality of the current secondary market pricing mechanism. This alignment between theoretical secondary discounts and actual acquisition outcomes indicates that private market participants are increasingly relying on these proxies to determine enterprise value.

Despite these concentrated pressures, the broader exit market shows signs of stabilization, with flat and down rounds falling to 13.1% of total deals. Median acquisition sizes have doubled to $200 million, supported by significant transactions such as ServiceNow’s $7.8 billion acquisition of Armis and Eli Lilly’s $7 billion purchase of Kelonia Therapeutics. These developments suggest that while the unicorn ecosystem remains largely unrealized, with 945 active unicorns holding an aggregate value of $5.3 trillion, strategic acquirers are beginning to find value outside of the primary AI hype cycle.

The reliance on nontraditional investors, who participated in 91.9% of US venture deal value this year, signals a shift in the composition of the capital base. Corporate venture arms, involved in 82.6% of deals, are playing an increasingly prominent role in sustaining these valuations. This influx of non-venture capital raises questions about the long-term sustainability of current pricing models if the exit window does not broaden beyond the limited number of successful public listings observed since 2025.

Market participants must now watch whether the 87.5% concentration figure holds in subsequent quarters and if the significant valuation discounts applied to 2021 vintages begin to narrow. The ability of the venture ecosystem to transition from a reliance on high-velocity AI funding to a more diversified exit environment remains the central challenge for the remainder of the year. Future data releases will determine if the current pricing of vintages is a temporary market anomaly or a structural shift in how private capital evaluates long-term growth.

The Checkup

A weekly newsletter focusing on the most important news in health and biotech.

More News

CoreWeave logo, featuring a blue stylized 'C' and a white stylized 'W'.

CoreWeave: AI Boom Meets Insider Exits

Despite AI boom enthusiasm and some bullish analyst ratings, CoreWeave’s stock dips and billions in insider selling hint at internal caution. Th...
Brass combination padlock on a credit card and laptop keyboard.

EU Weighs GDPR Relaxation for AI Growth

The European Commission is poised to unveil a “digital omnibus” package that could loosen GDPR and other privacy safeguards. This strategi...
"IBM logo on a white square over a blue circuit board pattern background."

IBM Stock Climbs on Strong Earnings

Strong earnings and revenue beats propelled IBM stock higher, as investors signal growing confidence in the tech titan’s pivot to hybrid cloud a...

At Global Business & Economics Journal, we contribute to the  future of business and technology with news,  innovative research, expert insights, and thought-provoking analysis.

The latest from
The Checkup: Our weekly biotech and health email

Sign up to get The Checkup weekly in your inbox.